Mito.newsMito.news
← All articlesEditorial brief · abstract-levelScore 74/100Confidence medium
biorxiv2026-09-04aginggliaredox biology

Doxorubicin and high glucose both senesce human microglia, but only high glucose turns NRF2-TFAM on

HMC3 microglia senesce under chronic doxorubicin or high glucose: hypertrophy, SA-beta-gal, less viability, p53-p21, lingering DNA-damage signaling. Metabolic stress also induces p16 and parks p21 at the nuclear rim. Mitochondria move in both cases: doxorubicin turns NRF2-TFAM down; high glucose turns that axis on and raises KEAP1, an antioxidant reply that still fails to restore mitochondrial content.

Mito.news · at a glance

Signal profile (abstract-level)

aging · glia · redox biology

Score 74/100BIORXIVmedium confidenceaging
74
Importance
50
Mito signal
67
Dysfunction
83
Evidence
38
Translational

Editorial signal profile from the abstract (importance score, mito keywords, dysfunction tags, evidence density, translational cues). Not a figure reproduced from the preprint PDF.

Finding. Human HMC3 microglia senesce two ways. Jose, Platt and colleagues hit them with doxorubicin or chronic high glucose. Both swell, turn SA-beta-gal on, lose metabolic viability, and light p53-p21 with leftover DNA-damage signaling. Glucose also raises p16 and sends p21 to the nuclear edge. Mitochondria disagree. Doxorubicin turns NRF2-TFAM down. Glucose turns that axis on and raises KEAP1, an antioxidant push that still does not put mitochondrial content back.

Score 74. Stressor-split mitochondrial biogenesis in microglial senescence. Medium confidence: line, truncated abstract.

Free HTML is above. Bots pay for JSON at /api/v1/papers/10-64898-2026-08-31-748228. Optional wallet tester: MetaMask ($0.005).

Source preprint

Genotoxic and metabolic stress drive divergent senescence programs in human microglia

10.64898/2026.08.31.748228

Jose NV, Janssens S, Kang E, Platt B.

Related briefs